Guidebook | How Biotech and Mid-Sized Pharma Can Build CMO Partnerships that Can Hold Under Pressure

When you're a mid-sized pharma or biotech company, external manufacturing isn't a support function – it is your supply chain.

This How-To Guide is designed to help you build stronger, more resilient pharma–CDMO partnerships. It brings together practical frameworks for benchmarking partner performance, establishing clear quality and contractual accountability, and strengthening collaboration to navigate capacity constraints, supply chain disruption and changing market demands.

With a focus on what drives performance in practice, the guide explores how greater transparency, effective communication, robust risk management, and digital visibility can help pharma and biotech teams move beyond transactional supplier relationships towards partnerships built for the long term.

Download the guidebook to learn how to:

• Benchmark CMO/CDMO performance across price, quality and speed, setting clear expectations and identifying where partnerships need to improve
• Strengthen quality agreements and accountability by clarifying responsibilities, aligning KPIs and establishing effective communication between partners
• Build more resilient external manufacturing networks that can respond to geopolitical disruption, changing capacity demands and supply chain risk
• Improve collaboration and visibility to reduce misalignment, support operational efficiency and strengthen decision-making across external manufacturing relationships

When your product supply depends on external manufacturers, a contract alone isn't enough. You need partners who share your priorities, communicate openly and can adapt as conditions change. Download the guidebook to benchmark your partnerships, strengthen performance and build greater resilience into your pharma supply chain.